RUNX1T1 and acute myeloid leukemia: Our four cases had AML with RUNX1::RUNX1T1 and KIT exon 17 mutations and all patients achieved complete morphological remission before allo-HSCT; however, RUNX1::RUNX1T1-positivity was found within 60 days after allo-HSCT.